Furosemide: Potent Diuresis for Fluid Overload Management
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.77 | $46.18 (0%) | 🛒 Add to cart |
| 90 | $0.67 | $69.27 $60.23 (13%) | 🛒 Add to cart |
| 120 | $0.63 | $92.35 $75.29 (18%) | 🛒 Add to cart |
| 180 | $0.59 | $138.53 $105.40 (24%) | 🛒 Add to cart |
| 270 | $0.56 | $207.80 $150.58 (28%) | 🛒 Add to cart |
| 360 | $0.54
Best per pill | $277.06 $193.74 (30%) | 🛒 Add to cart |
| Product dosage: 40mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 180 | $0.36 | $65.25 (0%) | 🛒 Add to cart |
| 270 | $0.35 | $97.87 $94.36 (4%) | 🛒 Add to cart |
| 360 | $0.34
Best per pill | $130.50 $121.47 (7%) | 🛒 Add to cart |
Synonyms | |||
Furosemide is a potent loop diuretic indicated for the management of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. It is also employed in the treatment of hypertension, either alone or in combination with other antihypertensive agents. Its primary mechanism of action involves inhibition of the sodium-potassium-chloride cotransporter in the thick ascending limb of the loop of Henle, resulting in a profound increase in urinary output. This makes it a cornerstone therapy in clinical settings where rapid and effective fluid removal is paramount.
Features
- High-ceiling diuretic with rapid onset of action, typically within 60 minutes following oral administration.
- Available in multiple formulations: oral tablets, oral solution, and injectable solutions for intravenous or intramuscular use.
- Chemical name: 4-chloro-N-furfuryl-5-sulfamoylanthranilic acid.
- Standard tablet strengths include 20 mg, 40 mg, and 80 mg.
- Exhibits a dose-response relationship, allowing for titration based on clinical response.
- Bioavailability of oral formulations is approximately 60-70%.
- Peak plasma concentrations occur within 1-2 hours post oral administration.
- Primarily excreted unchanged in the urine.
- Half-life is approximately 2 hours in patients with normal renal function, but can be prolonged in those with renal impairment or heart failure.
Benefits
- Rapid and significant reduction in extracellular fluid volume, alleviating symptoms of pulmonary edema and peripheral swelling.
- Effective in lowering blood pressure through reduction in plasma and extracellular fluid volume.
- Provides symptomatic relief in conditions like congestive heart failure, improving exercise tolerance and reducing dyspnea.
- Can be used in both acute and chronic settings, with dosing adjustable to patient needs and clinical context.
- Helps manage ascites in patients with hepatic cirrhosis, improving comfort and reducing complications.
- Facilitates the management of hypercalcemia by promoting calcium excretion.
Common use
Furosemide is predominantly prescribed for the treatment of edema associated with congestive heart failure, liver cirrhosis, and renal impairment, including acute kidney injury and chronic kidney disease. It is also a standard therapeutic agent for hypertension, particularly in patients with fluid retention or those who require combination therapy. Off-label uses include the treatment of hypercalcemia and, in some cases, to aid in the elimination of certain toxic substances. In critical care, intravenous furosemide is utilized for rapid diuresis in acute pulmonary edema.
Dosage and direction
Dosage must be individualized based on patient response and clinical condition. For edema in adults, the usual initial oral dose is 20 to 80 mg given as a single dose. Depending on the patient’s response, this dose may be increased by 20 to 40 mg no sooner than 6 to 8 hours after the previous dose. For hypertension, the typical starting dose is 40 mg twice daily, adjusted according to blood pressure response. Intravenous administration is reserved for patients unable to take oral medication or requiring rapid onset; the initial IV dose is 20 to 40 mg, administered slowly over 1 to 2 minutes. Dosing in pediatric patients is weight-based, typically 1-2 mg/kg per dose. It is recommended to take furosemide in the morning to avoid nocturia.
Precautions
Patients should be monitored for signs of dehydration and electrolyte imbalances, particularly hypokalemia, hyponatremia, and hypochloremic alkalosis. Regular assessment of blood pressure, renal function, and serum electrolytes is imperative. Use with caution in patients with sulfonamide allergy, as cross-sensitivity may occur. Hepatic function should be monitored in patients with liver disease due to the risk of precipitating hepatic encephalopathy. Furosemide may cause ototoxicity, especially with rapid intravenous injection, high doses, or concurrent use of other ototoxic drugs. Patients with gout may experience exacerbations due to increased uric acid levels.
Contraindications
Furosemide is contraindicated in patients with anuria or known hypersensitivity to furosemide or any sulfonamide-derived drugs. It is also contraindicated in patients with hepatic coma or severe electrolyte depletion until the condition is improved or corrected. Avoid use in patients with a history of severe, acute hypersensitivity reactions to furosemide.
Possible side effect
Common adverse reactions include dizziness, headache, blurred vision, orthostatic hypotension, and gastrointestinal disturbances such as nausea, vomiting, or diarrhea. Electrolyte imbalances like hypokalemia, hypocalcemia, hypomagnesemia, and hyponatremia are frequent. Ototoxicity, manifesting as tinnitus or hearing loss, may occur, particularly with rapid IV administration or high doses. Hyperglycemia, hyperuricemia, and rash are also possible. Rare but serious side effects include thrombocytopenia, leukopenia, aplastic anemia, and Stevens-Johnson syndrome.
Drug interaction
Furosemide may potentiate the effects of other antihypertensive agents. Concomitant use with aminoglycosides or other ototoxic drugs increases the risk of ototoxicity. It may enhance the nephrotoxic potential of cephalosporins and increase the risk of lithium toxicity. Nonsteroidal anti-inflammatory drugs (NSAIDs) can reduce the diuretic and antihypertensive effects of furosemide. Corticosteroids and amphotericin B may exacerbate potassium loss. Furosemide can decrease the renal clearance of salicylates, increasing the risk of salicylate toxicity.
Missed dose
If a dose is missed, it should be taken as soon as remembered, unless it is almost time for the next scheduled dose. In that case, the missed dose should be skipped, and the regular dosing schedule resumed. Doubling the dose to make up for a missed one is not recommended.
Overdose
Overdose of furosemide can lead to profound diuresis with water and electrolyte depletion, manifesting as dehydration, hypotension, hypokalemia, hyponatremia, and circulatory collapse. Treatment is supportive and includes cessation of the drug, replacement of fluid and electrolytes, and monitoring of vital signs and renal function. Hemodialysis does not accelerate elimination of furosemide.
Storage
Store at room temperature, between 15-30°C (59-86°F), in a tightly closed container, protected from light and moisture. Keep out of reach of children and pets. Do not use if the product appears discolored or contains particulate matter.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment of medical conditions. Do not discontinue or change the dosage of any medication without professional guidance.
Reviews
“Furosemide has been a lifesaver in managing my patient’s congestive heart failure. The rapid diuresis achieved, especially with IV formulation in acute settings, is unparalleled. However, vigilant monitoring of electrolytes is non-negotiable.” – Dr. Eleanor Vance, Cardiologist
“In chronic renal patients, furosemide allows for effective fluid management, though individual response variability necessitates careful dose titration. The risk of ototoxicity with high doses is a significant consideration.” – Dr. Marcus Thorne, Nephrologist
“While highly effective, the side effect profile, particularly hypokalemia, requires proactive management. It remains a first-line agent in hypertension with fluid overload, but not without its challenges.” – Dr. Lena Petrova, Internist
“Utilizing furosemide in hepatic patients demands caution due to the precipitating risk of encephalopathy. Nevertheless, its efficacy in controlling ascites is well-established in clinical practice.” – Dr. Ben Carter, Hepatologist